Axio raises $6 mn in Series B2 equity round led by TrueScale Capital

Axio Biosolutions, a Boston and Bengaluru-based medtech company, raised $6 million in a Series B2 equity raise led by TrueScale Capital, with participation from existing investors Omidyar Network India, University of California–Ratan Tata Fund, and Accel.

Axio Biosolutions Private Limited, India (Axio), a wholly-owned subsidiary of Boston-based Advamedica Inc is a developer of hemostatic and advanced wound care products. Sameer Nath, managing partner at TrueScale Capital, will join Axio’s board of directors. Prior to this round, Axio has raised capital from Accel, Chiratae Ventures, University of California–Ratan Tata Fund and Omidyar Network India.

“We are thrilled to welcome TrueScale Capital and look